IRIS
ZAMPINO, Rosa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 14.226
NA - Nord America 9.264
AS - Asia 5.883
SA - Sud America 923
Continente sconosciuto - Info sul continente non disponibili 473
AF - Africa 77
OC - Oceania 4
Totale 30.850
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.061
RU - Federazione Russa 8.957
SG - Singapore 2.207
IE - Irlanda 1.563
CN - Cina 1.166
HK - Hong Kong 1.012
IT - Italia 916
UA - Ucraina 794
BR - Brasile 766
GB - Regno Unito 670
VN - Vietnam 614
DE - Germania 450
SE - Svezia 253
FI - Finlandia 219
KR - Corea 194
TR - Turchia 192
GR - Grecia 154
JP - Giappone 147
IN - India 131
FR - Francia 102
CA - Canada 91
AR - Argentina 62
BD - Bangladesh 54
MX - Messico 37
AT - Austria 32
EC - Ecuador 30
IQ - Iraq 27
ID - Indonesia 23
NL - Olanda 23
BE - Belgio 21
ZA - Sudafrica 17
CO - Colombia 16
MA - Marocco 16
VE - Venezuela 15
PK - Pakistan 14
PL - Polonia 14
UZ - Uzbekistan 14
CL - Cile 13
ES - Italia 12
EU - Europa 12
JM - Giamaica 12
CR - Costa Rica 11
EG - Egitto 9
HN - Honduras 9
KE - Kenya 9
SA - Arabia Saudita 9
MY - Malesia 8
IL - Israele 7
IR - Iran 7
LT - Lituania 7
NI - Nicaragua 7
PE - Perù 7
SV - El Salvador 7
TN - Tunisia 7
AL - Albania 6
CW - ???statistics.table.value.countryCode.CW??? 6
PA - Panama 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
ET - Etiopia 5
KZ - Kazakistan 5
PH - Filippine 5
PT - Portogallo 5
RO - Romania 5
SN - Senegal 5
TT - Trinidad e Tobago 5
BH - Bahrain 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
HU - Ungheria 4
LB - Libano 4
NP - Nepal 4
UY - Uruguay 4
AU - Australia 3
AZ - Azerbaigian 3
BG - Bulgaria 3
GT - Guatemala 3
KG - Kirghizistan 3
KW - Kuwait 3
OM - Oman 3
PR - Porto Rico 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
BB - Barbados 2
CY - Cipro 2
CZ - Repubblica Ceca 2
EE - Estonia 2
GP - Guadalupe 2
JO - Giordania 2
PS - Palestinian Territory 2
AM - Armenia 1
AO - Angola 1
AW - Aruba 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
Totale 30.376
Salva come PNG Salva come JPEG
Città #
Moscow 3.102
Dublin 1.562
Jacksonville 1.202
Santa Clara 1.053
Hong Kong 999
Singapore 854
San Jose 787
Ashburn 734
Chandler 707
Council Bluffs 537
Princeton 264
New York 202
Roxbury 195
Seoul 191
Ho Chi Minh City 183
Milan 160
Beijing 146
Hanoi 144
Ann Arbor 143
Cambridge 142
Dallas 125
Woodbridge 121
Boardman 115
Wilmington 110
Bremen 108
Medford 106
Hefei 105
The Dalles 89
Bengaluru 61
Naples 60
Jinan 56
São Paulo 56
San Mateo 55
Des Moines 54
Munich 52
Los Angeles 51
Mountain View 50
Orem 50
Nanjing 48
Da Nang 46
Düsseldorf 45
Miano 42
Shenyang 42
Nuremberg 41
Memphis 33
Houston 29
Haiphong 28
Norwalk 28
Rome 28
Napoli 27
Bologna 26
Caserta 25
Washington 25
Atlanta 24
Chennai 24
Tokyo 24
Toronto 22
Belo Horizonte 21
Brussels 21
Changsha 19
Helsinki 19
Rio de Janeiro 19
Zhengzhou 19
Brasília 18
Frankfurt am Main 18
Guangzhou 18
Lanzhou 17
Tianjin 17
Ningbo 16
Biên Hòa 15
Brooklyn 15
Campinas 15
North Bergen 15
Amsterdam 14
Chicago 14
Marano Di Napoli 14
San Francisco 14
Haikou 13
Hangzhou 13
Montreal 13
Seattle 13
Taizhou 13
Baghdad 12
Bari 12
Salvador 12
Tashkent 12
Vienna 12
Charlotte 11
Guadalupe 11
Hebei 11
Hải Dương 11
Istanbul 11
London 11
Nanchang 11
Porto Alegre 11
Thái Bình 11
Thái Nguyên 11
Warsaw 11
Auburn Hills 10
Guayaquil 10
Totale 15.942
Salva come PNG Salva come JPEG
Nome #
Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C 221
Anti-envelope 1 and 2 immune response in chronic hepatitis C patients: Effects of hepatitis B virus co-infection and interferon treatment 205
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 200
Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C 194
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 187
Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review 187
Cannabinoid Receptor 2 (CB2) Q63 variant in chronic hepatitis C: an association with a more severe hepatocellular necrosis. 186
CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection. 183
Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms 182
Chronic HCV infection and neurological and psychiatric disorders: an overview. 171
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes 171
Analisi della regione del core promoter del virus dell’epatite B (HBV) in pazienti guariti da una malattia oncoematologica con infezione cronica da HBV o da HBV-HCV tre anni dopo sieroconversione ad anti-HBe. 170
Cannabinoid receptor 2 (CB2) Q63 variant is associated with a severe histological activity index in patients with chronic hepatitis C 168
Analisi della regione del core promoter del virus dell’epatite B (HBV) in pazienti guariti da una malattia oncoematologica con infezione cronica da HBV o da HBV-HCV tre anni dopo sieroconversione ad anti-HBe 165
Cardiovascular Risk in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals 164
Chronic hepatitis B infection in pediatric patients cured of oncologic diseases: natural history and effect of interferon treatment 163
The impact of the CB2-63 polymorphism on the histological presentation of chronic hepatitis B. 161
Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot study 161
Ruolo eziologico e patogenetico del virus dell'epatite C (HCV) nella crioglobulinemia mista (CM) in pazienti con epatite cronica (EC). 159
Chronic HCV Infection is risk of atherosclerosis. Role of HCV and HCV-related steatosis 159
Atherosclerosis and chronic hepatitis C virus (HCV) infection: Role of liver steatosis 159
Clinical efficacy and safety of cefiderocol for resistant gram-negative infections: a real-life, single center experience 158
Clinical results with the use of ceftaroline and ceftobiprole: real-life experience in a tertiary care hospital 158
Aspetti clinico terapeutici della crioglobulinemia mista associata all’epatite cronica C: esperienza su un ampia casistica. 158
. Cinetica precoce dell’HCV-RNA in pazienti con epatite cronica: correlati clinico-virologici e valore predittivo la risposta al trattamento antivirale 157
Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. 156
Clinical significance and prognostic value of hemostasis parameters in 337 patients with acute infective endocarditis 153
Nocardiosi polmonare in pazienti con trapianto di cuore: casi clinici 152
Prognostic Value of Decreased High-Density Lipoprotein Cholesterol Levels in Infective Endocarditis 152
A survey of adverse events in 11241 patients with chronic viral hepatitis treated with alfa interferon 151
Virological patterns of HCV patients with failure to interferon-free regimens. 150
Clinical evaluation of the safety and efficacy of enoxaparin in patients with COVID-19 148
Three-phase sequential combined treatment with lamivudine and interferon in young patients with chronic hepatitis B 146
L'endocardite da Enterococco: nostra esperienza nel periodo 1988-93. 146
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. 146
Infezioni polmonari micotiche e da nocardia nel paziente cardiotrapiantato: caratteristiche cliniche e trattamento 145
ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population 143
PNPLA3 l148M variant as a risk factor for carotid atherosclerosis in chronic epatiti C 142
Aspetti diagnostici di mutanti della regione HBsAg in pazienti immunocompromessi con riattivazione dell’infezione da virus dell’epatite B (HBV). 141
Hepatic steatosis and necro-inflammatory activity overestimated liver stiffness by transient elastography in staging liver fibrosis in chronic hepatitis C 141
Can we go for a shorter treatment course in chronic hepatitis C? More inspiring cases 141
Risk factors and outcome of multidrug-resistant infections after heart transplant: A contemporary single center experience 141
Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients 140
Ruolo patogenetico dell'adiponectina nella steatosi associata ad epatite C 140
Associating enterococcal endocarditis and colorectal neoplasia: is colonoscopy mandatory? – Authors’ reply 140
Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection 139
Treatment of chronic hepatitis B in children with prednisone followed by alpha-interferon: a controlled randomized study 139
Incidence, Risk Factors and Clinical Implications of Glucose Metabolic Changes after Heart Transplant 138
EFFICACIA DEL TRATTAMENTO CON INTERFERONE RICOMBINANTE E LINFOBLASTOIDE IN PAZIENTI CON EPATITE CRONICA DA HCV 138
No effect of MTP polymorphisms on PNPLA3 in HCV-correlated steatosis 138
Predictors of long-term mortality in left-sided infective endocarditis: an historical cohort study in 414 patients 138
Comparison of dual HBV-HCV versus single HBV or HCV infections in a previous oncologic pediatric population. 137
La epatite cronica da HCV con steatosi si associa ad elevato rischio aterosclerotico. 136
Celiachia silente in pazienti con epatite C: prevalenza, effetto del trattamento con alfa-interferone sull’attivazione della malattia ed evoluzione clinica 136
Immunocompromised patients with HBsAg a determinant mutants: comparison of HBsAg diagnostic assays 135
Esperienza con l'interferone linfoblastoide nelle epatiti croniche virali 135
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. 135
Favourable effect of alpha-interferon treatment in HBeAb/HBV-DNA positive chronic hepatitis B. 134
Anthropometric parameters and liver histology influence lipid metabolic changes in HCV chronic hepatitis on direct-acting antiviral treatment 134
HCV-related steatosis and risk of atherosclerosis 133
Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression. 132
Features of infective endocarditis in a contemporary cohort of persons who inject drugs: a matched comparison analysis of long-term prognostic factors 131
Interferon-induced anti-HBE seroconversion correlates with a Th1 cytokine shift following emergence of core promoter mutations in chronic hepatitis B 131
Leukocyte interferon-alpha and ribavirin for treatment of chronic hepatitis C patients intolerant to pegylated-interferon 131
Epidemiology, clinical spectrum and prognostic value of mixed cryoglobulinaemia in hepatitis C virus patients: a prospective study 131
Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C 130
HCV RNA levels in serum, liver and PBMC of chronic hepatitis C patients: pathological and therapeutic significance. 130
Efficacy and Safety of Fosfomycin Disodium in Patients with Bacterial Infections: A Single-Center, Real-Life Clinical Study 129
Le infezioni respiratorie da Branhamella catarrhalis in pazienti sottoposti a trapianto di cuore. 129
Comunicazione orale: Cinetica precoce dell’HCV-RNA in pazienti con epatite cronica: correlati clinico-virologici e valore predittivo la risposta al trattamento antivirale 129
Patatin-Like Phospholipase Domain-Containing 3 I148M Variant Is Associated with Liver Steatosis and Fat Distribution in Chronic Hepatitis B 129
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis. 128
Viral Hepatitis C 128
Dalbavancin treatment for spondylodiscitis: multi-center clinical experience and literature review 127
Core promoter mutations 3 years after anti-hepatitis B e seroconversion in patients with chronic hepatitis B or hepatitis B and C infection and cancer remission 127
Polimorfismo di IL28B nei soggetti con infezione cronica da HCV con transaminasi persistentemente normali e nei pazienti con epatite cronica d HCV 127
Long term effect of interferon (IFN) treatment of chronic hepatitis B (CHB) in pediatric patients cured of oncologic diseases 127
Inotropes administration in patients with acute infective endocarditis and indication for urgent cardiac surgery 126
Embolia maggiore nell’endocardite infettiva: associazione con l’età e la risposta di fase acuta 126
Effective itraconazole treatment of pulmonary aspergillosis in heart transplant patients 126
PNPLA3 I148M variant is associated with liver steatosis and fat distribution in chronic hepatitis B 126
Endotoxinemia contributes to steatosis, insulin resistance and atherosclerosis in chronic hepatitis C: the role of pro-inflammatory cytokines and oxidative stress 126
Tm6sf2 e167k variant is associated with severe steatosis in chronic hepatitis c, regardless of pnapl3 polymorphism 125
The TM6SFZ 8167K variant is an independent predictor of severe liver steatosis in chronic hepatitis C 125
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosi 125
Different serological, molecular and cytokine profiles characterize active and inactive disease in patients with chronic hepatitis B virus (HBV) infection 124
Ruolo patogenetico dell’adiponectina nella steatosi associata ad epatite C 124
La presenza della variante Q63 del recettore dei cannabinoidi (CB2) si associa ad un più severa epatonecrosi nei pazienti con epatite cronica C. 124
ESPERIENZA CON L'INTERFERONE LINFOBLASTOIDE NELLE EPATITI CRONICHE VIRALI 124
NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations. 124
Occult HBV infection in the oncohematological setting. 124
Treatment of chronic HBV infection in developing countries. 124
Drugs and liver injury: a not to be overlooked binomial in COVID-19 124
Long-Term Outcome of Infective Endocarditis Involving Cardiac Implantable Electronic Devices: Impact of Comorbidities and Lead Extraction 123
Effects of long-term alfa interferon treatment in 344 patients with chronic hepatitis C: retrospective analysis of dosage and type of interferon used 123
Efficacia del trattamento con interferone ricombinante e linfoblastoide in pazienti con epatite cronica da HCV. 123
Management of carbapenem resistant Enterobacteriaceae infections 123
Embolic complications in a large contemporary cohort of infective endocarditis: do we need score model? 122
Treatment of chronic hepatitis B: efficacy of current drugs and prospects for the future 122
Le infezioni delle basse vie urinarie: eziologia e suscettibilità agli antibiotici. Nostra esperienza negli ultimi 4 anni. 122
Totale 14.357
Salva come PNG Salva come JPEG
Categoria #
all - tutte 107.289
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.289
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.370 0 0 0 14 482 19 26 44 63 149 109 464
2022/20232.898 261 48 31 222 333 222 10 165 1.467 25 56 58
2023/20241.177 93 28 41 72 420 181 34 35 6 13 88 166
2024/20253.722 8 48 32 84 589 594 560 311 443 578 322 153
2025/202614.482 461 570 677 744 1.137 8.413 737 550 517 300 252 124
2026/20272.619 106 388 1.051 1.074 0 0 0 0 0 0 0 0
Totale 30.850